Literature DB >> 8023160

Potential role of human cytomegalovirus and p53 interaction in coronary restenosis.

E Speir1, R Modali, E S Huang, M B Leon, F Shawl, T Finkel, S E Epstein.   

Abstract

A subset of patients who have undergone coronary angioplasty develop restenosis, a vessel renarrowing characterized by excessive proliferation of smooth muscle cells (SMCs). Of 60 human restenosis lesions examined, 23 (38 percent) were found to have accumulated high amounts of the tumor suppressor protein p53, and this correlated with the presence of human cytomegalovirus (HCMV) in the lesions. SMCs grown from the lesions expressed HCMV protein IE84 and high amounts of p53. HCMV infection of cultured SMCs enhanced p53 accumulation, which correlated temporally with IE84 expression. IE84 also bound to p53 and abolished its ability to transcriptionally activate a reporter gene. Thus, HCMV, and IE84-mediated inhibition of p53 function, may contribute to the development of restenosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8023160     DOI: 10.1126/science.8023160

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  208 in total

Review 1.  Vascular smooth muscle cell apoptosis in atherosclerosis.

Authors:  J J Boyle
Journal:  Int J Exp Pathol       Date:  1999-08       Impact factor: 1.925

Review 2.  Early and late effects of radiation treatment for prevention of coronary restenosis: a critical appraisal.

Authors:  O F Bertrand; S Lehnert; R Mongrain; M G Bourassa
Journal:  Heart       Date:  1999-12       Impact factor: 5.994

Review 3.  [Angiology update].

Authors:  C Ranke; H J Trappe
Journal:  Med Klin (Munich)       Date:  1999-05-15

Review 4.  Glycoprotein IIb/IIIa receptor inhibition in interventional cardiology.

Authors:  C M Gibson; J L Moynihan; E N Al-Mousa; M Campsey; R Gandhi; S Murphy; S Mattson; K A Ryan; R Mesley; J Swanson; M N Arshad; S J Marble
Journal:  J Thromb Thrombolysis       Date:  1999-06       Impact factor: 2.300

5.  PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway.

Authors:  M Tan; Y Wang; K Guan; Y Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

6.  Cytomegalovirus seropositivity and incident ischaemic heart disease in the Caerphilly prospective heart disease study.

Authors:  D P Strachan; D Carrington; M A Mendall; B K Butland; P M Sweetnam; P C Elwood
Journal:  Heart       Date:  1999-03       Impact factor: 5.994

7.  Viable human cytomegalovirus recombinant virus with an internal deletion of the IE2 86 gene affects late stages of viral replication.

Authors:  Veronica Sanchez; Charles L Clark; Judy Y Yen; Roopashree Dwarakanath; Deborah H Spector
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

8.  Role of regulatory elements and the MAPK/ERK or p38 MAPK pathways for activation of human cytomegalovirus gene expression.

Authors:  Jiping Chen; Mark F Stinski
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

Review 9.  Herpesvirus lytic replication and the cell cycle: arresting new developments.

Authors:  E K Flemington
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

10.  Role of human cytomegalovirus immediate-early proteins in cell growth control.

Authors:  J P Castillo; A D Yurochko; T F Kowalik
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.